Product Information
CEVIMELINE HCL 30 MG CAPSULE is a generic product labeled by Advagen Pharma Ltd., priced at $0.6871 per EA under NDC 72888011801. Its NADAC has been published 143 times since Oct 4, 2023.
Strength
30 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888011801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEVIMELINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216682On Market Since
4/6/2023
Pharmacological Classes
Price Statistics
The NADAC for CEVIMELINE HCL 30 MG CAPSULE has been published 143 times since Oct 4, 2023, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6871 per EA |
|---|---|
| All-time high | $1.1715 (Oct 11, 2023) |
| All-time low | $0.6268 (Nov 20, 2024) |
| 52-week high | $0.7172 |
| 52-week low | $0.6572 |
| Median price | $0.7172 |
| Average price | $0.8154 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 143 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEVIMELINE HCL 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEVIMELINE HCL 30 MG CAPSULE, manufactured by Advagen Pharma Ltd., is $0.6871 per EA (NDC 72888011801), effective Jun 24, 2026.
How has the price of CEVIMELINE HCL 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has declined 41.3%. It has been tracked across 143 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for CEVIMELINE HCL 30 MG CAPSULE?
Since Oct 4, 2023, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has ranged from a low of $0.6268 (Nov 20, 2024) to a high of $1.1715 (Oct 11, 2023), with a median of $0.7172 per EA.
Are there cheaper alternatives to CEVIMELINE HCL 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CEVIMELINE HCL 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CEVIMELINE HCL 30 MG CAPSULE?
CEVIMELINE HCL 30 MG CAPSULE (NDC 72888011801) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification